Blujepa

Active Ingredient(s): Gepotidacin Mesylate
FDA Approved: * March 25, 2025
Pharm Company: * GLAXOSMITHKLINE
Category: Antibiotics
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Blujepa 750 mg Oral Tablet, Film Coated
NDC: 0173-0922
Labeler:
Glaxosmithkline LLC